TPG Group Holdings (SBS) Advisors’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.41M Hold
1,020,748
0.03% 43
2021
Q2
$2.73M Hold
1,020,748
0.02% 53
2021
Q1
$2.18M Hold
1,020,748
0.03% 57
2020
Q4
$2.52M Hold
1,020,748
0.03% 38
2020
Q3
$2.08M Hold
1,020,748
0.04% 38
2020
Q2
$3.02M Hold
1,020,748
0.05% 35
2020
Q1
$2.7M Hold
1,020,748
0.06% 35
2019
Q4
$5.07M Hold
1,020,748
0.07% 42
2019
Q3
$6.08M Hold
1,020,748
0.09% 46
2019
Q2
$6.58M Hold
1,020,748
0.1% 44
2019
Q1
$6.9M Hold
1,020,748
0.14% 44
2018
Q4
$4.15M Hold
1,020,748
0.07% 49
2018
Q3
$11.1M Buy
+1,020,748
New +$10.7M 0.14% 49

Other funds holding ETTX

TPG Group Holdings (SBS) Advisors's ETTX Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors held its Entasis Therapeutics Holdings Inc. (ETTX) position steady in Q3 2021 at 1,020,748 shares worth $3.41M. The position accounts for 0.03% of the portfolio, ranked #43.

TPG Group Holdings (SBS) Advisors first reported a position in ETTX in Q3 2018 and has held it in 13 quarters since. The position peaked at $11.1M in Q3 2018. 29 funds tracked by Wall St. Rank hold ETTX as of Q3 2021.

  • TPG Group Holdings (SBS) Advisors held 1,020,748 shares of Entasis Therapeutics Holdings Inc. worth $3.41M as of Q3 2021.
  • TPG Group Holdings (SBS) Advisors left its Entasis Therapeutics Holdings Inc. share count unchanged in Q3 2021.
  • Entasis Therapeutics Holdings Inc. made up 0.03% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #43 holding.
  • TPG Group Holdings (SBS) Advisors first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2018 and has held it in 13 quarters since.
  • TPG Group Holdings (SBS) Advisors's Entasis Therapeutics Holdings Inc. position peaked at $11.1M in Q3 2018.
  • 29 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.